In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Bruker Corp (NASDAQ: BRKR) closed at $34.72 up 6.86% from its previous closing price of $32.49. In other words, the price has increased by $6.86 from its previous closing price. On the day, 4.72 million shares were traded. BRKR stock price reached its highest trading level at $34.925 during the session, while it also had its lowest trading level at $32.52.
Ratios:
For a deeper understanding of Bruker Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 57.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 106.85. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.32.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $72.
On December 10, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $66.UBS initiated its Neutral rating on December 10, 2024, with a $66 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 12 ’25 when Friend Cynthia M sold 3,535 shares for $32.25 per share. The transaction valued at 113,990 led to the insider holds 18,016 shares of the business.
CYNTHIA FRIEND bought 3,535 shares of BRKR for $113,990 on Sep 12 ’25. On Jun 06 ’25, another insider, LAUKIEN FRANK H, who serves as the PRESIDENT & CEO of the company, bought 2,608 shares for $38.36 each. As a result, the insider paid 100,043 and bolstered with 38,462,171 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 5267696128 and an Enterprise Value of 7709296128. As of this moment, Bruker’s Price-to-Earnings (P/E) ratio for their current fiscal year is 66.27, and their Forward P/E ratio for the next fiscal year is 15.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 26.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 2.92. Its current Enterprise Value per Revenue stands at 2.239 whereas that against EBITDA is 13.826.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.20, which has changed by -0.506231 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $69.61, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 2.61%, while the 200-Day Moving Average is calculated to be -19.07%.
Shares Statistics:
For the past three months, BRKR has traded an average of 3.91M shares per day and 4045780 over the past ten days. A total of 151.72M shares are outstanding, with a floating share count of 102.94M. Insiders hold about 32.15% of the company’s shares, while institutions hold 82.60% stake in the company. Shares short for BRKR as of 1757894400 were 12188058 with a Short Ratio of 3.11, compared to 1755216000 on 6648568. Therefore, it implies a Short% of Shares Outstanding of 12188058 and a Short% of Float of 17.330000000000002.
Dividends & Splits
According to the company, the forward annual dividend rate for BRKR is 0.20, from 0.2 in the trailing year. Against a Trailing Annual Dividend Yield of 0.00615574. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
The market rating for Bruker Corp (BRKR) is a result of the insights provided by 12.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.86, with high estimates of $0.92 and low estimates of $0.76.
Analysts are recommending an EPS of between $2.03 and $1.8 for the fiscal current year, implying an average EPS of $1.96. EPS for the following year is $2.32, with 13.0 analysts recommending between $2.67 and $1.75.
Revenue Estimates
A total of 11 analysts believe the company’s revenue will be $848.04M this quarter.It ranges from a high estimate of $855M to a low estimate of $838.14M. As of. The current estimate, Bruker Corp’s year-ago sales were $864.4MFor the next quarter, 11 analysts are estimating revenue of $1B. There is a high estimate of $1.02B for the next quarter, whereas the lowest estimate is $972.3M.
A total of 11 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.47B, while the lowest revenue estimate was $3.42B, resulting in an average revenue estimate of $3.45B. In the same quarter a year ago, actual revenue was $3.37BBased on 11 analysts’ estimates, the company’s revenue will be $3.51B in the next fiscal year. The high estimate is $3.58B and the low estimate is $3.45B.
